Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.

导出 LinkOut

翻译打印收藏纠错

作者： Michael,Putman ^[1] ; Yu Pei Eugenia,Chock ^[2] ; Herman,Tam ^[3] ; Alfred H J,Kim ^[4] ; Sebastian E,Sattui ^[5] ; Francis,Berenbaum ^[6] ; Maria I,Danila ^[7] ; Peter,Korsten ^[8] ; Catalina,Sanchez-Alvarez ^[9] ; Jeffrey A,Sparks ^[10] ; Laura C,Coates ^[11] ; Candace,Palmerlee ^[12] ; Andrea,Peirce ^[13] ; Arundathi,Jayatilleke ^[14] ; Sindhu R,Johnson ^[15] ; Adam,Kilian ^[16] ; Jean,Liew ^[17] ; Larry J,Prokop ^[9] ; M Hassan,Murad ^[9] ; Rebecca,Grainger ^[18] ; Zachary S,Wallace ^[19] ; Alí,Duarte-García ^[9] ; COVID-19 Global Rheumatology Alliance

作者单位： Northwestern Medicine, Chicago, Illinois, United States. ^[1] Yale School of Medicine, New Haven, Connecticut, United States. ^[2] The Hospital for Sick Children, Toronto, Ontario, Canada. ^[3] Washington University School of Medicine, Saint Louis, Missouri, United States. ^[4] Hospital for Special Surgery, New York, New York, United States. ^[5] Sorbonne Université, INSERM CRSA, AP-HP Hôpital Saint Antoine, Paris, France. ^[6] University of Alabama at Birmingham. ^[7] University Medical Center Göttingen, Göttingen, Germany. ^[8] Mayo Clinic, Rochester, Minnesota, United States. ^[9] Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States. ^[10] University of Oxford, Oxford, UK. ^[11] ••, Berkeley, California, United States. ^[12] ••, New York, New York, United States. ^[13] Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States. ^[14] Toronto Western Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada. ^[15] George Washington University School of Medicine and Health Sciences, Washington, DC, United States. ^[16] University of Washington, Seattle. ^[17] University of Otago, Wellington, New Zealand. ^[18] Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States. ^[19]

主题词抗体, 单克隆(Antibodies, Monoclonal);抗风湿药(Antirheumatic Agents);吖丁啶类(Azetidines);氯喹(Chloroquine);疾病恶化(Disease Progression);糖皮质激素类(Glucocorticoids);人类(Humans);羟氯喹(Hydroxychloroquine);免疫球蛋白类, 静脉内(Immunoglobulins, Intravenous);免疫因子类(Immunologic Factors);白细胞介素1受体拮抗蛋白质(Interleukin 1 Receptor Antagonist Protein);比例危险度模型(Proportional Hazards Models);嘌呤类(Purines);吡唑类(Pyrazoles);磺胺类(Sulfonamides)

DOI 10.1002/art.41469

PMID 32741139

发布时间 2023-03-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Arthritis & rheumatology (Hoboken, N.J.)

2021年73卷1期

36-47页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.

Arthritis & rheumatology (Hoboken, N.J.)

相似文献

Arthritis & rheumatology (Hoboken, N.J.)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.

Arthritis & rheumatology (Hoboken, N.J.)

相似文献

Arthritis & rheumatology (Hoboken, N.J.)

相关期刊

检索历史清除